{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:40:46Z","timestamp":1792593646861,"version":"4.5.0"},"reference-count":36,"publisher":"MyJove Corporation","issue":"226","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69352","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:02:11Z","timestamp":1767139331000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Significance of Serum LDH Concentration in the Prognostic Assessment of Large Cell Neuroendocrine Lung Cancer"],"prefix":"10.3791","author":[{"given":"Mengyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"653162","DOI":"10.3389\/fonc.2021.653162","type":"journal-article","article-title":"Management of large cell neuroendocrine carcinoma","volume":"11","author":"Corbett","year":"2021","unstructured":"Corbett, V., Arnold, S., Anthony, L., et al. Management of large cell neuroendocrine carcinoma. Frontiers in Oncology. 11, 653162 (2021).","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/jcm11051461","type":"journal-article","article-title":"Large cell neuroendocrine carcinoma of the lung: current understanding and challenges","volume":"11","author":"Andrini","year":"2022","unstructured":"Andrini, E., Marchese, P. V., De Biase, D., et al. Large cell neuroendocrine carcinoma of the lung: current understanding and challenges. Journal of Clinical Medicine. 11(5), 1461 (2022).","journal-title":"Journal of Clinical Medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1610730","DOI":"10.3389\/pore.2022.1610730","type":"journal-article","article-title":"Pulmonary large cell neuroendocrine carcinoma","volume":"28","author":"Yang","year":"2022","unstructured":"Yang, L., Fan, Y., Lu, H. Pulmonary large cell neuroendocrine carcinoma. Pathology & Oncology Research. 28, 1610730 (2022).","journal-title":"Pathology & Oncology Research"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/PAS.0000000000001740","type":"journal-article","article-title":"Urinary large cell neuroendocrine carcinoma: a clinicopathologic analysis of 22 cases","volume":"45","author":"Wang","year":"2021","unstructured":"Wang, G., Yuan, R., Zhou, C., et al. Urinary large cell neuroendocrine carcinoma: a clinicopathologic analysis of 22 cases. American Journal of Surgical Pathology. 45(10), 1399-1408 (2021).","journal-title":"American Journal of Surgical Pathology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12885-023-10797-3","type":"journal-article","article-title":"Incidence, survival comparison, and novel prognostic evaluation approaches for stage III-IV pulmonary large cell neuroendocrine carcinoma and small cell lung cancer","volume":"23","author":"Huang","year":"2023","unstructured":"Huang, L., Feng, Y., Xie, T., et al. Incidence, survival comparison, and novel prognostic evaluation approaches for stage III-IV pulmonary large cell neuroendocrine carcinoma and small cell lung cancer. BMC Cancer. 23(1), 312 (2023).","journal-title":"BMC Cancer"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1038\/s41598-021-92430-6","type":"journal-article","article-title":"Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases","volume":"11","author":"Wu","year":"2021","unstructured":"Wu, Y., Lu, C., Pan, N., et al. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Scientific Reports. 11(1), 12997 (2021).","journal-title":"Scientific Reports"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41467-025-57906-3","type":"journal-article","article-title":"Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer","volume":"16","author":"Deng","year":"2025","unstructured":"Deng, H., Zhao, L., Ge, H., et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nature Communications. 16(1), 2597 (2025).","journal-title":"Nature Communications"},{"issue":"12","key":"ref8","first-page":"749","type":"journal-article","article-title":"The multiple roles of LDH in cancer. Nature Reviews","volume":"19","author":"Claps","year":"2022","unstructured":"Claps, G., Faouzi, S., Quidville, V., et al. The multiple roles of LDH in cancer. Nature Reviews Clinical Oncology. 19(12), 749-762 (2022).","journal-title":"Clinical Oncology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2022.11.032","type":"journal-article","article-title":"Rationale for LDH-targeted cancer immunotherapy","volume":"181","author":"Miholjcic","year":"2023","unstructured":"Miholjcic, T. B. S., Halse, H., Bonvalet, M., et al. Rationale for LDH-targeted cancer immunotherapy. European Journal of Cancer. 181, 166-178 (2023).","journal-title":"European Journal of Cancer"},{"key":"ref10","type":"book","volume-title":"Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. In: Seminars in Cancer Biology","author":"Sharma","year":"2022","unstructured":"Sharma, D., Singh, M., Rani, R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. In: Seminars in Cancer Biology. Academic Press; 87, 184-195 (2022)."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1758835920942378","DOI":"10.1177\/1758835920942378","type":"journal-article","article-title":"Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score","volume":"12","author":"Galvano","year":"2020","unstructured":"Galvano, A., Peri, M., Guarini, A. A., et al. Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score. Therapeutic Advances in Medical Oncology. 12, 1758835920942378 (2020).","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/cncr.34113","type":"journal-article","article-title":"Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer","volume":"128","author":"Tjokrowidjaja","year":"2022","unstructured":"Tjokrowidjaja, A., Lord, S. J., John, T., et al. Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer. Cancer. 128(8), 1574-1583 (2022).","journal-title":"Cancer"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12967-021-02825-2","type":"journal-article","article-title":"Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench","volume":"19","author":"Yang","year":"2021","unstructured":"Yang, Y., Chong, Y., Chen, M., et al. Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench. Journal of Translational Medicine. 19(1), 170 (2021).","journal-title":"Journal of Translational Medicine"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.21037\/jtd-22-1502","type":"journal-article","article-title":"Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study","volume":"14","author":"Wang","year":"2022","unstructured":"Wang, S., Lv, J., Lv, J., et al. Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study. Journal of Thoracic Disease. 14(11), 4468 (2022).","journal-title":"Journal of Thoracic Disease"},{"issue":"8","key":"ref15","first-page":"621","type":"journal-article","article-title":"Recent Advances and Controversies in Minute Pulmonary Meningothelial-like Nodules","volume":"26","author":"Li","year":"2023","unstructured":"Li, H. et al. Recent Advances and Controversies in Minute Pulmonary Meningothelial-like Nodules. Zhongguo Fei Ai Za Zhi. 26 (8), 621-629 (2023).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","type":"journal-article","article-title":"The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer","volume":"12","author":"Chansky","year":"2017","unstructured":"Chansky, K., Detterbeck, F. C., Nicholson, A. G., et al. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. Journal of Thoracic Oncology. 12(7), 1109-1121 (2017).","journal-title":"Journal of Thoracic Oncology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"650293","DOI":"10.3389\/fonc.2021.650293","type":"journal-article","article-title":"Large cell neuro-endocrine carcinoma of the lung: current treatment options and potential future opportunities","volume":"11","author":"Ferrara","year":"2021","unstructured":"Ferrara, M. G., Stefani, A., Simbolo, M., et al. Large cell neuro-endocrine carcinoma of the lung: current treatment options and potential future opportunities. Frontiers in Oncology. 11, 650293 (2021).","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.21037\/tlcr-24-292","type":"journal-article","article-title":"Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma","volume":"13","author":"Liu","year":"2024","unstructured":"Liu, T., Chen, X., Mo, S., et al. Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma. Translational Lung Cancer Research. 13(9), 2222 (2024).","journal-title":"Translational Lung Cancer Research"},{"key":"ref19","type":"book","volume-title":"The prognostic significance of lung immune prognostic index (LIPI) and pan-immune-inflammation value (PIV) in patients with large cell neuroendocrine carcinoma","author":"Menekse","year":"2022","unstructured":"Menekse, S. The prognostic significance of lung immune prognostic index (LIPI) and pan-immune-inflammation value (PIV) in patients with large cell neuroendocrine carcinoma. (2022)."},{"issue":"5","key":"ref20","type":"journal-article","article-title":"Correlation analysis of serum LDH concentration before and after operation and prognosis of large cell neuroendocrine lung cancer patients","volume":"24","author":"Haocheng","year":"2021","unstructured":"Haocheng, W., Dongfeng, S., Ya, D., et al. Correlation analysis of serum LDH concentration before and after operation and prognosis of large cell neuroendocrine lung cancer patients. Zhongguo Fei Ai Za Zhi. 24(5) (2021).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13023-024-03240-8","type":"journal-article","article-title":"Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience","volume":"19","author":"Liu","year":"2024","unstructured":"Liu, L., Zhang, J., Zhao, K., et al. Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience. Orphanet Journal of Rare Diseases. 19(1), 232 (2024).","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4103\/jcrt.jcrt_2443_22","type":"journal-article","article-title":"Clinical features and prognosis of advanced intra- and extra-pulmonary neuroendocrine carcinomas","volume":"19","author":"Chen","year":"2023","unstructured":"Chen, X. Y., Guo, N. J., Guo, P. L., et al. Clinical features and prognosis of advanced intra- and extra-pulmonary neuroendocrine carcinomas. Journal of Cancer Research and Therapeutics. 19(4), 951-956 (2023).","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.3390\/cancers13133249","type":"journal-article","article-title":"Interrelations between patients' clinicopathological characteristics and their association with response to immunotherapy in a real-world cohort of NSCLC patients","volume":"13","author":"Callejo","year":"2021","unstructured":"Callejo, A., Frigola, J., Iranzo, P., et al. Interrelations between patients' clinicopathological characteristics and their association with response to immunotherapy in a real-world cohort of NSCLC patients. Cancers. 13(13), 3249 (2021).","journal-title":"Cancers"},{"key":"ref24","type":"book","volume-title":"Preliminary analysis of progression-free survival results for atezolizumab plus platinum etoposide as first-line treatment in metastatic lung large-cell neuroendocrine carcinoma patients","author":"Evangelou","year":"2025","unstructured":"Evangelou, G., Vamvakaris, I., Nikolaidou, V., et al. Preliminary analysis of progression-free survival results for atezolizumab plus platinum etoposide as first-line treatment in metastatic lung large-cell neuroendocrine carcinoma patients. (2025)."},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/diagnostics15091056","type":"journal-article","article-title":"Pulmonary large-cell neuroendocrine carcinoma, a multifaceted disease-case report and literature review","volume":"15","author":"Constantin","year":"2025","unstructured":"Constantin, A. A., Cotea, A. A., Mih\u0103l\u021ban, F. D. Pulmonary large-cell neuroendocrine carcinoma, a multifaceted disease-case report and literature review. Diagnostics. 15(9), 1056 (2025).","journal-title":"Diagnostics"},{"key":"ref26","first-page":"1293","type":"journal-article","article-title":"Serum NSE is early marker of transformed neuroendocrine tumor after EGFR-TKI treatment of lung adenocarcinoma","volume":"2023","author":"Mao","year":"2023","unstructured":"Mao, X., Liu, J., Hu, F., et al. Serum NSE is early marker of transformed neuroendocrine tumor after EGFR-TKI treatment of lung adenocarcinoma. Cancer Management and Research. 2023, 1293-1302 (2023).","journal-title":"Cancer Management and Research"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41416-020-01188-7","type":"journal-article","article-title":"Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment","volume":"124","author":"Shirasawa","year":"2021","unstructured":"Shirasawa, M., Yoshida, T., Horinouchi, H., et al. Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment. British Journal of Cancer. 124(5), 925-932 (2021).","journal-title":"British Journal of Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.2147\/CMAR.S300153","type":"journal-article","article-title":"Combining lactate dehydrogenase and fibrinogen: potential factors to predict therapeutic efficacy and prognosis of patients with small-cell lung cancer","volume":"2021","author":"Huang","year":"2021","unstructured":"Huang, W., Liu, P., Zong, M., et al. Combining lactate dehydrogenase and fibrinogen: potential factors to predict therapeutic efficacy and prognosis of patients with small-cell lung cancer. Cancer Management and Research. 2021, 4299-4307 (2021).","journal-title":"Cancer Management and Research"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ph16010037","type":"journal-article","article-title":"Afatinib reverses EMT via inhibiting CD44-Stat3 axis to promote radiosensitivity in nasopharyngeal carcinoma","volume":"16","author":"Huang","year":"2023","unstructured":"Huang, H., Huang, F. Afatinib reverses EMT via inhibiting CD44-Stat3 axis to promote radiosensitivity in nasopharyngeal carcinoma. Pharmaceuticals. 16(1), 37 (2023).","journal-title":"Pharmaceuticals"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"103016","DOI":"10.1016\/j.redox.2023.103016","type":"journal-article","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","unstructured":"Zhang, Y., Zhu, et al. M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages. Redox Biology. 69, 103016 (2024).","journal-title":"Redox Biology"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","type":"journal-article","article-title":"Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles","volume":"18","author":"Pei","year":"2024","unstructured":"Pei, W., Zhang, Y., et al. Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles. ACS Nano. 18(4), 2782-2799 (2024).","journal-title":"ACS Nano"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/cbr.2015.1921","type":"journal-article","article-title":"Regulation of oncoprotein 18\/Stathmin signaling by ERK concerns the resistance to Taxol in nonsmall cell lung cancer cells","volume":"31","author":"Lin","year":"2016","unstructured":"Lin, X., Liao, Y., et al. Regulation of oncoprotein 18\/Stathmin signaling by ERK concerns the resistance to Taxol in nonsmall cell lung cancer cells. Cancer Biotherapy and Radiopharmaceuticals. 31(2), 37-43 (2016).","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","type":"journal-article","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","unstructured":"Gong, H., Liu, Z., et al. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Computers in Biology and Medicine. 171, 108198 (2024).","journal-title":"Computers in Biology and Medicine"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"2530004","DOI":"10.1142\/S1793545825300046","type":"journal-article","article-title":"Activatable fluorescent probes for imaging and diagnosis of hepatocellular carcinoma","volume":"18","author":"Men","year":"2024","unstructured":"Men, X., Liu, F., et al. Activatable fluorescent probes for imaging and diagnosis of hepatocellular carcinoma. Journal of Innovative Optical Health Sciences. 18(3), 2530004 (2024).","journal-title":"Journal of Innovative Optical Health Sciences"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13578-024-01213-9","type":"journal-article","article-title":"Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Notch1 pathway via modifying SOX2 degradation","volume":"14","author":"Luo","year":"2024","unstructured":"Luo, C., Yu, Y., et al. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Notch1 pathway via modifying SOX2 degradation. Cell & Bioscience. 14(1), 35 (2024).","journal-title":"Cell & Bioscience"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1039\/D2MO00261B","type":"journal-article","article-title":"Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer","volume":"19","author":"Wang","year":"2023","unstructured":"Wang, N., Zhao, Q., et al. Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Molecular Omics. 19(3), 238-251 (2023).","journal-title":"Molecular Omics"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69352\/clinical-significance-serum-ldh-concentration-prognostic-assessment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:58:33Z","timestamp":1792591113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69352\/clinical-significance-serum-ldh-concentration-prognostic-assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":36,"journal-issue":{"issue":"226","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/69352","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}